AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $798 | +49.4% | 518,467 | -7.8% | 0.00% | 0.0% |
| Q2 2023 | $534 | -6.8% | 562,567 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $573 | -6.8% | 573,367 | -33.5% | 0.00% | 0.0% |
| Q4 2022 | $615 | -99.9% | 862,267 | -29.4% | 0.00% | 0.0% |
| Q3 2022 | $785,000 | -45.1% | 1,222,141 | -21.4% | 0.00% | -50.0% |
| Q2 2022 | $1,431,000 | +22.5% | 1,555,800 | +75.8% | 0.00% | +100.0% |
| Q1 2022 | $1,168,000 | -5.5% | 885,100 | +175.7% | 0.00% | -50.0% |
| Q4 2021 | $1,236,000 | -45.3% | 321,000 | -20.8% | 0.00% | -33.3% |
| Q3 2021 | $2,260,000 | +185.7% | 405,100 | +355.2% | 0.00% | +200.0% |
| Q2 2021 | $791,000 | +39.8% | 89,000 | +119.2% | 0.00% | 0.0% |
| Q4 2020 | $566,000 | +184.4% | 40,600 | +165.4% | 0.00% | – |
| Q3 2020 | $199,000 | -68.8% | 15,300 | -58.1% | 0.00% | -100.0% |
| Q2 2020 | $637,000 | +145.9% | 36,530 | +129.7% | 0.00% | – |
| Q2 2019 | $259,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |